![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2024-financial-results-and-reaffirms-2024-financial-outlook/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215971
https://www.fiercepharma.com/pharma/teva-racks-approval-new-formulation-its-cns-blockbuster-waiting-austedo
https://www.fiercepharma.com/pharma/teva-looks-humira-biosimilar-leans-ajovy-and-austedo-spark-faltering-growth
https://www.fiercepharma.com/pharma/after-abbvie-phrmas-black-sheep-teva-walks-away-influential-trade-group
https://www.fiercepharma.com/pharma/teva-s-austedo-struggling-from-pandemic-slowdown-needs-huge-gains-to-meet-company-s-2021
https://www.businesswire.com/news/home/20211021005210/en/Teva-to-Present-New-Data-from-Growing-Mental-Health-Portfolio-at-Psych-Congress-2021
https://www.fiercepharma.com/marketing/teva-launches-inaugural-branded-campaign-for-movement-disorder-drug
https://www.biospace.com/article/releases/teva-to-present-new-data-on-austedo-deutetrabenazine-tablets-at-the-mds-virtual-congress-2020-and-psych-congress-2020-virtual-experience/
http://www.pmlive.com/pharma_news/tevas_weak_pipeline_hit_by_tourettes_drug_trial_failure_1326565
https://www.fiercepharma.com/pharma/teva-s-global-restructuring-over-now-it-s-looking-to-ajovy-austedo-for-next-phase
https://www.reuters.com/article/us-teva-pharm-ind-cluster-headache/teva-stops-testing-its-migraine-drug-as-cluster-headache-treatment-idUSKCN1RZ1EH?feedType=RSS&feedName=healthNews
https://www.fiercepharma.com/pharma/jpm-wrapup-must-reads-from-a-week-biopharma-news-chosen-by-you
https://www.fiercepharma.com/pharma/as-td-drugs-get-more-play-docs-are-coming-around-to-teva-s-austedo-analyst